none

CSIRO HELPS SLEEP DISORDER START-UP MAKE ITS DEBUT

22-07-2016
by 
in 

CSIRO partner Oventus Medical Ltd has today listed on the Australian Securities Exchange raising $12m.

The CSIRO and their partners Oventus Medical ltd, that manufacture sleep apnoea devices, have listed on the Australian Securities Exchange raising $12 million.

The company has been working with the CSIRO over the last two and a half years to help create their product and grow business.

Oventus, a Melbourne based company, was approached by the CSIRO in 2014 after dentist Chris Hart had an idea for a mouthguard that would help airflow bypass for any obstructions in a sleep apnoea sufferers airway.

Sleep apnoea is when the walls of the throat come together during sleep, blocking off the upper airway and breathing often stops for a period of time. 

Dr Hart had asked CSIRO if they could 3D-print the device dubbed O2Vent™ from titanium, which resulted in the initial prototype that has since successfully completed its clinical trials.

In April this year, the device received FDA clearance opening up the US market for the company.

The O2Vent is a customisable mouthpiece which is 3D-printed to the precise dimensions of a patient’s mouth, ensuring optimal airflow during sleep, reducing the effects of snoring and sleepapnoea.

Oventus Founder Dr Hart said CSIRO provided the opportunity to access new 3D-printing technologies through their Lab22 facility.

"This allowed us to explore new and innovative manufacturing techniques with a reduced investment risk,” Dr Hart said.

“Using 3D-printing to manufacture the O2Vent sleep apnoea devices offered us huge advantages over traditional manufacturing methods including speed and cost.

"This partnership has made us globally competitive," he said.

Oventus is hoping O2Vent will disrupt the multi-billion dollar market for sleep apnoea solutions.

An estimated one million Australians suffer from sleep apnoea.

The product’s prototype was first made in  he CSIRO’s Lab 22 Innovation Centre in Victoria, using an Arcam 3D printer.

CSIRO’s Mr Stefan Gulizia said the idea of designing and 3D-printing completely customised mouthpieces seemed revolutionary at the time.

“It has been exciting helping Oventus progress this novel idea to a manufactured product and seeing the success of the company as it lists on the ASX today,” Mr Gulizia said.

Oventus’ fully-subscribed IPO has raised $12 million that will be injected into the commercialisation and distribution of their O2Vent sleep apnoea devices.

Related news & editorials

  1. 18.01.2019
    18.01.2019
    by      In
    Mouser Electronics has revealed that it added no fewer than 51 new suppliers to its industry-leading line card in 2018, offering even more choices to its design engineer, component buyer, and procurement agent customer base.
    With many new embedded suppliers among the additions, Mouser is... Read More
  2. 18.01.2019
    18.01.2019
    by      In
    Phoenix Contact has come out with its first high-performance controller for the PLCnext technology ecosystem. The RFC 4072S controller takes advantage of all the main features of the control platform, including the ability for users to program using their favourite languages and programming... Read More
  3. 17.01.2019
    17.01.2019
    by      In
    The Exair Gen4 Super Ion Air Wipe provides a uniform 360-degree ionised airstream that is clamped around a continuously moving part to eliminate static electricity and contaminants. It is ideal for removing dust, particulates and personnel shocks on pipe, cable, extruded shapes, hose, wire and more... Read More
  4. 17.01.2019
    17.01.2019
    by      In
    With many areas of Australia facing severe drought, the Government has launched its $12.9 million Water for the Future plan focusing on more efficient water infrastructure and refurbishment of older pipes and systems.
    Helping to realise this programme, Air Springs Supply has released a new range of... Read More